retatrutide triple agonist obesity trial First phase 3 data, a Triumph of Science! Retatrutide produces up to 30.3%

These EECs are classified based on the hormones they produce, such as serotonin-producing enterochromaffin cells (ECs), cholecystokini (CCK)-producing I-cells, GIP-producing K-cells, GLP-1 producing L-cells, somatostatin (SST)-producing D-cells, neurotensin (NTS)-producing N-cells, secretin (SCT)-producing S-cells and ghrelin (GHRL)-producing X cells

Sleep issues and depression seem to go hand in hand, with both insomnia and hypersomnia (sleeping too much) being common complaints of people with depression

When combined with testosterone, monitor for unexplained fatigue, mood changes, or loss of testosterone therapy benefits, which may signal the need for dose adjustments

For people using compounded drug products, checking the COA is a big part of being safe